Investigation Overview
The announcement by Celera Corporation that its board of directors agreed to a takeover by Quest Diagnostics Inc. immediately prompted investigations on behalf of investors of Celera Corporation (NASDAQ:CRA) concerning potential unfairness of the takeover and possible breaches of fiduciary duty. The investigations by law firms concers whether certain directors and officers at Celera ...
You must register (for free) or login to view the entire investigation.